Scholar Rock Holding (SRRK) Gains from Investment Securities (2017 - 2026)
Scholar Rock Holding's quarterly Gains from Investment Securities came in at $7.6 million in Q1 2026, up 707.56% year-on-year from $942116.0 in Q1 2025, and up 8946.66% quarter-over-quarter from -$86000.0 in Q4 2025.
Scholar Rock Holding has reported Gains from Investment Securities for 10 years, with the latest figure at $7.6 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 707.56% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (up 707.56% YoY), and the FY2025 full-year result was $7.8 million, down 7.37% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $7.6 million, up from -$86000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $9.2 million in Q2 2024, with the low at -$864000.0 in Q4 2024.
- Average Gains from Investment Securities over 5 years is $2.6 million, with a median of $1.5 million recorded in 2023.
- Year-over-year, Gains from Investment Securities surged 23830.77% in 2023 and slumped 128.01% in 2024.
- Tracing SRRK's Gains from Investment Securities over 5 years: stood at -$13000.0 in 2022, then surged by 23830.77% to $3.1 million in 2023, then plunged by 128.01% to -$864000.0 in 2024, then soared by 90.05% to -$86000.0 in 2025, then surged by 8946.66% to $7.6 million in 2026.
- The last three Gains from Investment Securities figures came in at $7.6 million (Q1 2026), -$86000.0 (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.61 Mn |
| Mar 31, 2026 | 7.61 Mn |
| Dec 31, 2025 | -86,000.00 |
| Dec 31, 2025 | -86,000.00 |
| Sep 30, 2025 | 8.91 Mn |
| Sep 30, 2025 | 8.91 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 942,116.00 |
| Mar 31, 2025 | 942,116.00 |
| Dec 31, 2024 | -864,000.00 |
| Dec 31, 2024 | -864,000.00 |
| Sep 30, 2024 | 2.84 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 9.17 Mn |
| Jun 30, 2024 | 9.17 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 3.09 Mn |
| Dec 31, 2023 | 3.09 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | -13,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Sep 30, 2022 | 3.16 Mn |
| Sep 30, 2022 | 3.16 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 902,092.00 |
| Mar 31, 2022 | 902,092.00 |
| Dec 31, 2021 | 517,000.00 |
| Dec 31, 2021 | 517,000.00 |
| Sep 30, 2021 | 705,014.00 |
| Sep 30, 2021 | 705,014.00 |
| Jun 30, 2021 | 4.32 Mn |
| Jun 30, 2021 | 4.32 Mn |
| Mar 31, 2021 | 259,007.00 |
| Mar 31, 2021 | 259,007.00 |
| Sep 30, 2020 | 4.14 Mn |
| Sep 30, 2020 | 4.14 Mn |
| Jun 30, 2020 | 1.47 Mn |
| Jun 30, 2020 | 1.47 Mn |
| Mar 31, 2020 | 732,000.00 |
| Mar 31, 2020 | 732,000.00 |
| Dec 31, 2019 | 13,000.00 |
| Dec 31, 2019 | 13,000.00 |
| Sep 30, 2019 | 2.47 Mn |
| Sep 30, 2019 | 2.47 Mn |
| Jun 30, 2019 | 2.42 Mn |
| Jun 30, 2019 | 2.42 Mn |
| Mar 31, 2019 | 5.35 Mn |
| Mar 31, 2019 | 5.35 Mn |
| Dec 31, 2018 | 139,000.00 |
| Dec 31, 2018 | 139,000.00 |
| Sep 30, 2018 | 1.51 Mn |
| Sep 30, 2018 | 1.51 Mn |
| Jun 30, 2018 | 1.48 Mn |
| Jun 30, 2018 | 1.48 Mn |
| Dec 31, 2017 | 45,000.00 |
| Dec 31, 2017 | 45,000.00 |